12473 results for
Refine Your Search
Secura Bio Announces Final Patient Enrolled in PRIMO Study and Inclusion of COPIKTRA® (duvelisib) in NCCN Guidelines for PTCL
SUMMERLIN, Nev., Feb. , - Secura Bio, Inc. announced that it completed enrollment on February , , in the PRIMO study. PRIMO is evaluating COPIKTRA (d…
Timothy Graubert
Dr. Graubert is Professor of Medicine at Harvard Medical School and Director of the Hematologic Malignancy Program at the Massachusetts General Hospit…
Exploiting Vulnerabilities in RNA Splicing to Treat Hematologic Malignancies
RNA splicing is a central metabolic pathway that is frequently perturbed in hematopoietic malignancies (HMs) that harbor mutations in spliceosome comp…
Improving the outcomes of young Black adults diagnosed with acute myeloid leukemia
Young Black patients diagnosed with acute myeloid leukemia (AML) have significantly shorter survival compared to White patients. To comprehensively as…
Ann-Kathrin Eisfeld
Eisfeld is a Assistant Professor and whose research focuses on acute myeloid leukemia genetics, as well as age-, gender- and differences in mutatio…
Michael
On January , , I was diagnosed with Burkitt’s lymphoma(BL)with brain metastasis, and kidney and liver failure. During my four rounds of chemo, I had g…
Micah
My wife was diagnosed with acute lymphoblastic leukemia (ALL) in June of . For nine months I watched her battle her cancer and her treatments. I lear…
Lynn
My wife, Lynn Lancour, spent endless time and resources organizing a bicycle trip from San Diego to St. Augustine, approximately , miles, to raise fun…
Leigh
In August , I developed pneumonia for the third time in two years. I had been finding that my ability to fight off illness was not as good as it used …
Krista
Prior to my diagnosis, I was a daughter to my parents, a dedicated dog mama to my Golden Retriever, a loyal friend, and an enthusiastic high school h…
Karrah
I was first diagnosed with acute lymphoblastic leukemia (ALL) in June of . Like a whirlwind, I spent the next nine months fighting for my life, battl…
John
In January , I had returned to my home outside of Charleston, South Carolina, from a -day assignment to Anchorage, Alaska. Even though I had returned …
Hudson
Hudson entered the world on March , . This is the day my heart left my own chest and was beating outside of my body. My whole world was immediately co…
It's Time To Understand CAR-T Therapy For B-Cell Lymphoma: Earlier Indications Coming To A Community Near You
Part of in a series on: The Evolving Role of CAR Therapy for R/R Lymphomas: Improving Access and Outcomes
Lily
I thought to myself, "Look at you, strong, independent, and ready for new adventures on the East Coast!" I then turned and boarded my flight to Maryla…
Jan
After returning from a diving trip to Cyprus in November , I started having headaches and sweating at night. Just two weeks later, I was diagnosed wit…
FDA Approves New Drug for Patients with Rare Blood Cancer (Myelofibrosis)
The Food and Drug Administration (FDA) recently approved a drug for the treatment of intermediate or primary or secondary myelofibrosis, the first sp…
Support Resources
Catherine Smith
Dr. Smith is a whose laboratory focuses on therapeutic resistance mechanisms and novel treatment strategies for acute myeloid leukemia (AML).
El estudio más importante hasta la fecha demuestra que la mayoría de los pacientes con cáncer de la sangre se benefician de una tercera dosis primaria de la vacuna contra la COVID-19 de tipo ARNm
El estudio respalda la recomendación de los Centros para el Control y la Prevención de Enfermedades (CDC, por sus siglas en inglés) para adultos inmun…
Un nuevo estudio demuestra que la mayoría de los pacientes con cáncer de la sangre se benefician de una dosis adicional de la vacuna contra la COVID-19
Los tratamientos inmunosupresores, un componente esencial de gran parte de la atención médica para el cáncer de los pacientes, pueden disminuir la res…